BNPとNT-proBNPの世界市場レポート 2025年

BNPとNT-proBNP市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.3％で36億米ドルに成長します。予測期間の成長は、心血管疾患負担の増加、ポイントオブケア検査への統合、他の病状への応用拡大、個別化医療アプローチ、遠隔医療、遠隔モニタリングに起因すると考えられます。予測期間における世界の動向には、アッセイ法の技術的進歩、個別化医療へのアプローチ、予後予測におけるバイオマーカー、新規バイオマーカーの出現、世界の標準化への取り組みなどが含まれます。

心血管系疾患の増加は、今後のBNPとNT-proBNP市場の成長を牽引すると予測されます。心血管疾患には、末梢動脈疾患、脳血管疾患、冠動脈性心疾患など、心臓や血管に影響を及ぼす疾患が含まれます。BNPとNT-proBNPの検査は、心臓の健康と安全性のモニタリングに重点を置き、心血管疾患の発症前にその要因を特定することで、予防措置の実施や死亡リスクの低下に役立ちます。例えば、2024年5月、米国の政府機関である疾病管理予防センター（CDC）は、心血管疾患に関連する死亡が33秒に1人発生し、2022年には心臓疾患が70万2880人（死亡者数のおよそ5人に1人）を占めると報告しました。心血管疾患の罹患率の増加がBNPとNT-proBNP市場を牽引しています。

老年人口層の拡大はBNPとNT-proBNP市場拡大の原動力になると予測されます。このセグメントは65歳以上の高齢者で構成され、心不全の診断と管理においてBNPとNT-proBNP検査が重要な助けとなります。これらのバイオマーカーは心機能に関する貴重な洞察を提供し、高齢者に合わせた治療戦略を支援します。世界保健機関（WHO）の報告によると、2030年までに世界の6人に1人が60歳以上になり、2050年には21億人の高齢者に達すると予測されています。したがって、急増する高齢者人口がBNPとNT-proBNP市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界BNPとNT-proBNP PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のBNPとNT-proBNP市場：成長率分析
• 世界のBNPとNT-proBNP市場の実績：規模と成長, 2019-2024
• 世界のBNPとNT-proBNP市場の予測：規模と成長, 2024-2029, 2034F
• 世界BNPとNT-proBNP総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のBNPとNT-proBNP市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• BNP（脳性ナトリウム利尿ペプチド）
• NT-proBNP（N末端プロB型ナトリウム利尿ペプチド）
• 世界のBNPとNT-proBNP市場テスト場所別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポイントオブケア検査
• 臨床検査
• 世界のBNPとNT-proBNP市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心筋梗塞
• うっ血性心不全
• 急性冠症候群（ACS）
• その他の用途
• 世界のBNPとNT-proBNP市場、BNPのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• BNP検査キット
• ポイントオブケアBNP検査装置
• ラボBNPアッセイ
• 世界のBNPとNT-proBNP市場NT-ProBNPのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• NT-ProBNP検査キット
• ポイントオブケア NT-proBNP検査装置
• ラボ用NT-ProBNPアッセイ
• 世界のBNPとNT-proBNP市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 統合サービス
• サポートおよびメンテナンスサービス
• トレーニングサービス

第7章 地域別・国別分析

• 世界のBNPとNT-proBNP市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のBNPとNT-proBNP市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• BNPとNT-proBNP市場：競合情勢
• BNPとNT-proBNP市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Gentian Diagnostics ASA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quidel Corporation
• Bio-Rad Laboratories Inc.
• F Hoffman La Roche Ltd.
• CTK Biotech Inc.
• RayBiotech Life Inc.
• BHR Pharmaceuticals Ltd.
• Getein Biotech Inc.
• VACURE Biotechnology Co. Ltd.
• Bio-Techne Co.
• Xiamen Biotime Biotechnology Co. Ltd.
• Scripps Laboratories Inc.
• Danaher Corporation
• Beckman Coulter Inc.
• Thermo Fisher Scientific Inc.
• Randox Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• BNPとNT-proBNP市場2029：新たな機会を提供する国
• BNPとNT-proBNP市場2029：新たな機会を提供するセグメント
• BNPとNT-proBNP市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests are diagnostic assessments gauging the levels of either BNP or its precursor hormone NT-proBNP in the blood. These tests serve as indicators for heart failure and various cardiac conditions. BNP and NT-proBNP, categorized as natriuretic peptides, hold pivotal roles in regulating circulation. Elevated levels of BNP or NT-proBNP typically signify underlying heart disease, specifically abnormalities in blood pumping.

These tests primarily involve measuring the quantities of BNP (brain natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) in the bloodstream. The BNP test specifically targets BNP levels, aiding in the detection of heart failure and other cardiac conditions. Testing locations encompass both point-of-care and laboratory settings, facilitating diagnostics for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), and other related ailments.

The BNP and NTproBNP market research report is one of a series of new reports from The Business Research Company that provides BNP and NTproBNP market statistics, including the BNP and NTproBNP industry global market size, regional shares, competitors with a BNP and NTproBNP market share, detailed BNP and NTproBNP market segments, market trends, and opportunities, and any further data you may need to thrive in the BNP and NTproBNP industry. This BNP and NTproBNP market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from$2.01 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to aging population, clinical utility in heart failure diagnosis, advancements in cardiovascular medicine, focus on preventive healthcare

The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.6 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in other medical conditions, personalized medicine approaches, telemedicine and remote monitoring. Major trends in the forecast period include technological advancements in assay methods, personalized medicine approaches, biomarker in predicting prognosis, emergence of novel biomarkers, global standardization efforts.

The increasing occurrence of cardiovascular diseases is anticipated to drive the growth of the BNP and NTproBNP market in the future. Cardiovascular diseases encompass conditions that impact the heart and blood vessels, including peripheral arterial disease, cerebrovascular disease, and coronary heart disease, among others. Tests for BNP and NTproBNP focus on monitoring heart health and safety, identifying factors that contribute to cardiovascular disease prior to its onset, which aids in implementing preventive measures and lowering the risk of mortality. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a government agency in the US, reported that a death related to cardiovascular disease occurs every 33 seconds, with heart disease accounting for 702,880 deaths in 2022-roughly one in five fatalities. The growing incidence of cardiovascular diseases is propelling the BNP and NTproBNP markets.

The expanding geriatric demographic is anticipated to be a driving force for the BNP and NTproBNP market's expansion. This segment, comprising individuals aged 65 or older, finds critical assistance from BNP and NTproBNP tests in diagnosing and managing heart failure. These biomarkers provide valuable insights into cardiac function, aiding in tailored treatment strategies for elderly individuals. The World Health Organization reports that by 2030, one in six individuals globally will be 60 or older, projected to reach 2.1 billion elderly individuals by 2050. Hence, the burgeoning geriatric population propels the growth of the BNP and NTproBNP market.

Innovation in product development emerges as a significant trend driving the BNP and NTproBNP markets. Leading companies in these markets prioritize introducing novel products to maintain their market positions. For instance, in May 2023, Randox Laboratories unveiled a BNP1-32 diagnostic test for heart failure diagnosis. This automated test measures BNP levels with high sensitivity and specificity, integrating with third-party controls and software for effective QC data monitoring. This control ensures accurate and reliable BNP testing.

Prominent companies in the BNP and NTproBNP market are intensifying their focus on rapid screening bioassays to gain a competitive edge. Rapid screening bioassays efficiently assess substance presence or concentration by measuring effects on living cells or organisms, aiding in swift and reliable attribute identification or condition categorization. Mindray Medical International Limited, in October 2023, introduced two new assays-high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). These assays bolster Mindray's ability to screen, risk-stratify, diagnose rapidly, and monitor therapy for cardiovascular diseases, enhancing their portfolio for efficient disease management. Mindray's collaboration with HyTest further strengthens its immunoassay platforms, integrating advanced research and antibodies for cardiac biomarkers.

In July 2024, Roche Holding AG, a pharmaceutical and diagnostics company based in Switzerland, acquired LumiraDx Limited for an undisclosed sum. This acquisition is intended to strengthen Roche's diagnostics portfolio by incorporating advanced point-of-care technology that facilitates quick testing for BNP and NT-proBNP. LumiraDx Limited, located in the UK, is known for its innovative rapid test for NT-proBNP.

Major companies operating in the bnp and ntprobnp market include Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2024. North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bnp and ntprobnp market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The BNP and NTproBNP market includes revenues earned by companies by providing diagnostic and heart disease detection services using BNP (B-type natriuretic peptide) or NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) as biomarkers, BNP and NTproBNP assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

BNP And NTproBNP Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bnp and ntprobnp market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bnp and ntprobnp ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bnp and ntprobnp market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: BNP (Brain Natriuretic Peptide); NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
• 2) By Location Of Testing: Point Of Care Testing; Laboratory Testing
• 3) By Application: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome (ACS); Other Applications
• Subsegments:
• 1) By BNP (Brain Natriuretic Peptide): BNP Testing Kits; Point-Of-Care BNP Testing Devices; Laboratory BNP Assays
• 2) By NT-ProBNP (N-Terminal Pro-B-Type Natriuretic Peptide): NT-ProBNP Testing Kits; Point-Of-Care NT-proBNP Testing Devices; Laboratory NT-ProBNP Assays
• Companies Mentioned: Abbott Laboratories; Gentian Diagnostics ASA; Siemens AG; PerkinElmer Inc.; Biomerieux SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. BNP And NTproBNP Market Characteristics

3. BNP And NTproBNP Market Trends And Strategies

4. BNP And NTproBNP Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global BNP And NTproBNP Growth Analysis And Strategic Analysis Framework

• 5.1. Global BNP And NTproBNP PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global BNP And NTproBNP Market Growth Rate Analysis
• 5.4. Global BNP And NTproBNP Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global BNP And NTproBNP Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global BNP And NTproBNP Total Addressable Market (TAM)

6. BNP And NTproBNP Market Segmentation

• 6.1. Global BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BNP (Brain Natriuretic Peptide)
• NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
• 6.2. Global BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point of Care Testing
• Laboratory Testing
• 6.3. Global BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome (ACS)
• Other Applications
• 6.4. Global BNP And NTproBNP Market, Sub-Segmentation Of BNP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BNP Testing Kits
• Point-Of-Care BNP Testing Devices
• Laboratory BNP Assays
• 6.5. Global BNP And NTproBNP Market, Sub-Segmentation Of NT-ProBNP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NT-ProBNP Testing Kits
• Point-Of-Care NT-proBNP Testing Devices
• Laboratory NT-ProBNP Assays
• 6.6. Global BNP And NTproBNP Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Integration Services
• Support And Maintenance Services
• Training Services

7. BNP And NTproBNP Market Regional And Country Analysis

• 7.1. Global BNP And NTproBNP Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global BNP And NTproBNP Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific BNP And NTproBNP Market

• 8.1. Asia-Pacific BNP And NTproBNP Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China BNP And NTproBNP Market

• 9.1. China BNP And NTproBNP Market Overview
• 9.2. China BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India BNP And NTproBNP Market

• 10.1. India BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan BNP And NTproBNP Market

• 11.1. Japan BNP And NTproBNP Market Overview
• 11.2. Japan BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia BNP And NTproBNP Market

• 12.1. Australia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia BNP And NTproBNP Market

• 13.1. Indonesia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea BNP And NTproBNP Market

• 14.1. South Korea BNP And NTproBNP Market Overview
• 14.2. South Korea BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe BNP And NTproBNP Market

• 15.1. Western Europe BNP And NTproBNP Market Overview
• 15.2. Western Europe BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK BNP And NTproBNP Market

• 16.1. UK BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany BNP And NTproBNP Market

• 17.1. Germany BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France BNP And NTproBNP Market

• 18.1. France BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy BNP And NTproBNP Market

• 19.1. Italy BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain BNP And NTproBNP Market

• 20.1. Spain BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe BNP And NTproBNP Market

• 21.1. Eastern Europe BNP And NTproBNP Market Overview
• 21.2. Eastern Europe BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia BNP And NTproBNP Market

• 22.1. Russia BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America BNP And NTproBNP Market

• 23.1. North America BNP And NTproBNP Market Overview
• 23.2. North America BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA BNP And NTproBNP Market

• 24.1. USA BNP And NTproBNP Market Overview
• 24.2. USA BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada BNP And NTproBNP Market

• 25.1. Canada BNP And NTproBNP Market Overview
• 25.2. Canada BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America BNP And NTproBNP Market

• 26.1. South America BNP And NTproBNP Market Overview
• 26.2. South America BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil BNP And NTproBNP Market

• 27.1. Brazil BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East BNP And NTproBNP Market

• 28.1. Middle East BNP And NTproBNP Market Overview
• 28.2. Middle East BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa BNP And NTproBNP Market

• 29.1. Africa BNP And NTproBNP Market Overview
• 29.2. Africa BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa BNP And NTproBNP Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. BNP And NTproBNP Market Competitive Landscape And Company Profiles

• 30.1. BNP And NTproBNP Market Competitive Landscape
• 30.2. BNP And NTproBNP Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Gentian Diagnostics ASA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis

31. BNP And NTproBNP Market Other Major And Innovative Companies

• 31.1. Quidel Corporation
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. F Hoffman La Roche Ltd.
• 31.4. CTK Biotech Inc.
• 31.5. RayBiotech Life Inc.
• 31.6. BHR Pharmaceuticals Ltd.
• 31.7. Getein Biotech Inc.
• 31.8. VACURE Biotechnology Co. Ltd.
• 31.9. Bio-Techne Co.
• 31.10. Xiamen Biotime Biotechnology Co. Ltd.
• 31.11. Scripps Laboratories Inc.
• 31.12. Danaher Corporation
• 31.13. Beckman Coulter Inc.
• 31.14. Thermo Fisher Scientific Inc.
• 31.15. Randox Laboratories Ltd.

32. Global BNP And NTproBNP Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The BNP And NTproBNP Market

34. Recent Developments In The BNP And NTproBNP Market

35. BNP And NTproBNP Market High Potential Countries, Segments and Strategies

• 35.1 BNP And NTproBNP Market In 2029 - Countries Offering Most New Opportunities
• 35.2 BNP And NTproBNP Market In 2029 - Segments Offering Most New Opportunities
• 35.3 BNP And NTproBNP Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer